CVS Health (CVS, Health Care Services) Stock Valuation & Fair Value Favorable on our tests
CVS Health (CVS, Health Care Services) trades at a blended P/E of 11.2, about 17% below its historical normal valuation, with a forward growth estimate of 10.0% and a PEG of 1.12. Analysts' one-year estimates have been hit 64% of the time. Priced at its historical normal P/E of 13.5 on the same blended earnings, the 2026-10-02 close of $86.46 corresponds to about $105 a share. This is a valuation reference, not a price target.
- Price $87.80 at the 2026-10-08 close, 0.9% below the 20-day average ($88.59) and 5.9% below the 50-day ($93.28).
- RSI (14) at 43.2.
- 52-week range $69.04 to $109.92: the price is 20.1% below the high and 27.2% above the low.
The Street vs SeerForecast
Wall Street's mean price target for CVS is $116.28 across 25 analysts, 32.4% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating moved from mixed on our tests (2026-06-03) to favorable on our tests (2026-10-05). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 37 weeks
Frequently asked questions
Is CVS Health stock overvalued?
At a blended P/E of 11.2 versus its historical normal P/E of 13.5, CVS Health trades about 17% below its typical valuation, with a PEG of 1.12 on 10.0% forward growth. tickerseer currently rates it favorable on our tests.
What is CVS Health's fair value and PEG?
CVS Health trades at a blended P/E of 11.2 against a historical normal P/E of 13.5, a PEG of 1.12, and a forward growth estimate of 10.0%. Priced at its historical normal P/E of 13.5 on the same blended earnings, the 2026-10-02 close of $86.46 corresponds to about $105 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of CVS Health changed?
tickerseer's rating moved from mixed on our tests (2026-06-03) to favorable on our tests (2026-10-05). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.
What is the analyst price target for CVS Health?
The mean Wall Street price target for CVS Health is $116.28 across 25 analysts, 32.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.